Table 4. Prevalence of uropathogens in women with UCPPS with and without flares in VB1 and VB2.
No. (%) | |||||||
---|---|---|---|---|---|---|---|
|
|||||||
Enterobacter | Enterococcus | Escherichia | Klebsiella | Proteus | Pseudomonas | Any Uropathogen | |
VB1: | |||||||
No flare (127) | 0 (0) | 4 (3.1) | 6 (4.7) | 2 (1.6) | 0 (0) | 1 (0.8) | 12 (9.4) |
Flare (86) | 0 (0) | 4 (4.7) | 4 (4.7) | 1 (1.2) | 0 (0) | 1 (1.2) | 7 (8.1) |
p Unadjusted | - | 0.574 | 0.9802 | 0.803 | - | 0.7818 | 0.7424 |
p Adjusted* | - | 0.4996 | 0.8632 | 0.6449 | - | 0.7253 | 0.5677 |
VB2: | |||||||
No flare (127) | 0 (0) | 1 (0.8) | 2 (1.6) | 0 (0) | 2 (1.6) | 0 (0) | 5 (3.9) |
Flare (83) | 1 (1.2) | 0 (0) | 0 (0) | 0 (0) | 1 (1.2) | 2 (2.4) | 1 (1.2) |
p Unadjusted | 1.000 | 0.7625 | 0.9957 | - | 0.9957 | 0.9966 | 0.5505 |
p Adjusted* | 1.000 | 0.6369 | 0.9971 | - | 0.9971 | 0.9978 | 0.9059 |
These data refer to nonculture identification technique since all subjects had standard culture sterile VB2 urine sample.
Adjusted for employment (employed, disabled or other) and race.